Angiotensin-(1-7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation

被引:103
作者
Esteban, Vanesa
Heringer-Walther, Silvia
Sterner-Kock, Anja
de Bruin, Ron
van den Engel, Sandra
Wang, Yong
Mezzano, Sergio
Egido, Jesus
Schultheiss, Heinz-Peter
Ruiz-Ortega, Marta
Walther, Thomas
机构
[1] Cellular Biology in Renal Diseases Laboratory, Fundación Jimenez Diaz, Universidad Autónoma Madrid, Madrid
[2] Department of Obstetrics, University of Leipzig, Leipzig
[3] Department of Cardiology, Charité, Campus Benjamin Franklin (CBF), Berlin
[4] Institute for Veterinary Pathology, Freie Universität, Berlin
[5] Department of Surgery, Erasmus-Medical Center, Rotterdam
[6] Centre for Biomedical Research, Hull York Medical School, University of Hull, Hull
[7] Division of Nephrology, School of Medicine, Universidad Austral, Valdivia
来源
PLOS ONE | 2009年 / 4卷 / 04期
关键词
HEMATOPOIETIC RECOVERY; MICE LACKING; KIDNEY; NEPHROPATHY; ACTIVATION; EXPRESSION; CHEMOKINES; BLOCKADE; FIBROSIS; SYSTEM;
D O I
10.1371/journal.pone.0005406
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Angiotensin (Ang) II mediates pathophysiologial changes in the kidney. Ang-(1-7) by interacting with the G protein-coupled receptor Mas may also have important biological activities. In this study, renal deficiency for Mas diminished renal damage in models of renal insufficiency as unilateral ureteral obstruction and ischemia/reperfusion injury while the infusion of Ang-(1-7) to wild-type mice pronounced the pathological outcome by aggravating the inflammatory response. Mas deficiency inhibited NF-kappa B activation and thus the elevation of inflammation-stimulating cytokines, while Ang-(1-7) infusion had proinflammatory properties in experimental models of renal failure as well as under basal conditions. The Ang-(1-7)-mediated NF-kappa B activation was Mas dependent but did not involve Ang II receptors. Therefore, the blockade of the NF-kappa B-activating properties of the receptor Mas could be a new strategy in the therapy of failing kidney.
引用
收藏
页数:12
相关论文
共 42 条
[1]   Ischemic nephropathy: Clinical characteristics and treatment [J].
Alcazar, JM ;
Rodicio, JL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (05) :883-893
[2]   Cell type-specific expression of the Mas proto-oncogene in testis [J].
Alenina, N ;
Baranova, T ;
Smirnow, E ;
Bader, M ;
Lippoldt, A ;
Patkin, E ;
Walther, T .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (05) :691-695
[3]   THE MAS ONCOGENE ENHANCES ANGIOTENSIN-INDUCED [CA-2+]I RESPONSES IN CELLS WITH PREEXISTING ANGIOTENSIN-II RECEPTORS [J].
AMBROZ, C ;
CLARK, AJL ;
CATT, KJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1133 (01) :107-111
[4]   Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity [J].
Bürgelová, M ;
Kramer, HJ ;
Teplan, V ;
Thumová, M ;
Cervenka, L .
KIDNEY INTERNATIONAL, 2005, 67 (04) :1453-1461
[5]   Effect of inhibitors of the renin-angiotensin system and other anti hypertensive drugs on renal outcomes: systematic review and meta-analysis [J].
Casas, JP ;
Chua, WL ;
Loukogeorgakis, S ;
Vallance, P ;
Smeeth, L ;
Hingorani, AD ;
MacAllister, RJ .
LANCET, 2005, 366 (9502) :2026-2033
[6]   Progression in chronic kidney disease [J].
Eddy, AA .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (04) :353-365
[7]   Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice [J].
Ellefson, DD ;
diZerega, GS ;
Espinoza, T ;
Roda, N ;
Maldonado, S ;
Rodgers, KE .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (01) :15-24
[8]   Angiotensin II, via AT1 and AT2 receptors and NF-κB pathway, regulates the inflammatory response in unilateral ureteral obstruction [J].
Esteban, V ;
Lorenzo, O ;
Rupérez, M ;
Suzuki, Y ;
Mezzano, S ;
Blanco, J ;
Kretzler, M ;
Sugaya, T ;
Egido, J ;
Ruiz-Ortega, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1514-1529
[9]   Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology [J].
Ferrario, CM .
CURRENT HYPERTENSION REPORTS, 2003, 5 (02) :129-134
[10]   Angiotensin I, angiotensin II and their biologically active peptides [J].
Ferrario, CM .
JOURNAL OF HYPERTENSION, 2002, 20 (05) :805-807